FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

2 Outdated Proposed Rules on Gene Therapies and Crabmeat Withdrawn

[ Price : $8.95]

Federal Register Notice: FDA withdraws two proposed rules published over five years ago because they are outdated.

Thermo Fisher PMA for Lung Cancer Assay

[ Price : $8.95]

Thermo Fisher Scientific files the final module of a PMA for its Oncomine Universal Dx Test, a multi-gene, next-generation sequenc...

FDA Wants eSubmissions to Conform to Data Standards

[ Price : $8.95]

FDA says it has amended its electronic submission Technical Rejection Criteria for Study Data to require study data standards in c...

FDA Rejects Dynavax BLA on Heplisav-B

[ Price : $8.95]

FDA sends Dynavax Technologies a Complete Response Letter on its BLA for Heplisav-B [hepatitis B vaccine, recombinant (adjuvanted)...

Comments Sought on Biologic Deviation Reporting Extension

[ Price : $8.95]

Federal Register Notice: FDA seeks comments on an OMB submission to extend an information collection on the Reporting of Biologica...

Device Firm Pays $36 Million Over Misbranding Charges

[ Price : $8.95]

Pennsylvania-based medical device manufacturer Biocompatibles pleads guilty to misbranding its embolic device LC Bead and will pay...

FDA Approves Gileads new Hepatitis B Therapy

[ Price : $8.95]

FDA approves a Gilead Sciences NDA for Vemlidy (tenofovir alafenamide, TAF) 25mg, a once-daily treatment for adults with chronic h...

FDA Grants Seattle Genetics Breakthrough Status for Adcetris

[ Price : $8.95]

FDA grants Seattle Genetics a breakthrough therapy designation for Adcetris (brentuximab vedotin) for treating patients with CD30-...

Retrophin Gains FDA Agreement on Retrophin Phase 3 Trial

[ Price : $8.95]

Retrophin reaches an agreement with FDA under a Special Protocol Assessment for a Phase 3 clinical trial evaluating RE-024, an in...

Trump Transition Healthcare Team Shapes Up

[ Price : $8.95]

President-elect Donald Trump reportedly selected former HHS official Andrew Bremberg to lead the transition team for HHS.